US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

FUNDX FUTURE FUND OPPORTUNITIES ETF

28.27

+0.14040.50%

Post-market: 28.270.0010+0.00%16:10 EDT

Volume:15.39K

Turnover:435.55K

Market Cap:228.55M

PE:- -

High:28.33

Open:28.32

Low:28.25

Close:28.13

52wk High:31.30

52wk Low:25.44

Shares:8.09M

Float Shares:8.09M

Volume Ratio:1.24

T/O Rate:0.19%

Dividend:0.50

Dividend Rate:1.75%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Halozyme Director Matthew L. Posard Disposes of Common Shares Worth USD 2.02 Million

Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

Guardant Health on Track for Record High Close

Japanese Firms Break Ranks to Demand Stronger Yen as Currency Woes Mount

Brazil's Central Bank Trims Rate to 13.75% as Tight Election Race Clouds Future Easing

Halozyme Therapeutics Slips on $1.05 Bln Convertible Offering Plans

Halozyme announces proposed offering of $1.05B of 2033 convertible senior notes

Halozyme Plans USD 1.05 Billion Convertible Senior Notes Offering Due 2033

Halozyme Therapeutics, - Expects to Use Net Proceeds to Repurchase Outstanding 2027 and 2028 Convertible Notes

THOMSON REUTERS

Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes Due 2033

THOMSON REUTERS

FireFox Gold Uncovers New High-Grade Lammas Zone at Mustajärvi Project in Finland

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live

Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20

Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027

THOMSON REUTERS

Halozyme CEO Helen Torley Reports Disposal of Common Shares Worth USD 6.5 Million

UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)

Guardant Health Price Target Announced at $203.00/Share by Rothschild & Co

Guardant Health's Breast Cancer Diagnostic Approved by US FDA

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/FFOX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FFOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFOX\",,,,,undefined,":{"symbol":"FFOX","market":"US","secType":"STK","nameCN":"FUNDX FUTURE FUND OPPORTUNITIES ETF","latestPrice":28.269,"timestamp":1789675200000,"preClose":28.1286,"halted":0,"volume":15385,"hourTrading":{"tag":"盘后","latestPrice":28.27,"preClose":28.269,"latestTime":"16:10 EDT","volume":6,"amount":169.614,"timestamp":1789675804068,"change":0.001,"changeRate":0.000035,"amplitude":0},"delay":0,"changeRate":0.004991361105778447,"floatShares":8085000,"shares":8085000,"eps":0,"marketStatus":"Closed","change":0.1404,"latestTime":"09-17 16:00:00 EDT","open":28.3201,"high":28.33,"low":28.25,"amount":435552,"amplitude":0.002844,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":28.1286,"sharesOutstanding":7155000,"nav":28.12,"aum":227350200,"dividendRate":0.017514,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.27,"preClose":28.269,"latestTime":"16:10 EDT","volume":6,"amount":169.614,"timestamp":1789675804068,"change":0.001,"changeRate":0.000035,"amplitude":0},"volumeRatio":1.240526},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFOX\",,,,,undefined,":{"symbol":"FFOX","floatShares":8085000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.240526,"shares":8085000,"dividePrice":0.4951,"high":28.33,"amplitude":0.002844,"preClose":28.1286,"low":28.25,"week52Low":25.44,"pbRate":"--","week52High":31.295,"institutionHeld":0,"latestPrice":28.269,"eps":0,"divideRate":0.017514,"volume":15385,"delay":0,"ttmEps":0,"open":28.3201,"prevYearClose":27.27,"prevWeekClose":28.55,"prevMonthClose":29.2799,"prevQuarterClose":30.29,"fiveDayClose":28.3455,"twentyDayClose":30.52,"sixtyDayClose":28.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FFOX\",params:#limit:5,,,undefined,":[{"date":"2025-12-31","symbol":"FFOX","amount":0.49447507,"announcedDate":"2025-12-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"FUNDX FUTURE FUND OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-02","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FFOX\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-31","recordDate":"2025-12-31","paymentDate":"2026-01-02","value":0.49447507,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FFOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FFOX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668999797","title":"Halozyme Director Matthew L. Posard Disposes of Common Shares Worth USD 2.02 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999797","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999797?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:20","pubTimestamp":1789680029,"startTime":"0","endTime":"0","summary":"Halozyme director Matthew L. Posard disposes of common shares worth USD 2.02 millionHalozyme director Matthew L. Posard sold 18,996 common shares on Sept. 16, 2026 at prices averaging about $106.13 to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL71YqMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Halozyme Director Matthew L. Posard Disposes of Common Shares Worth USD 2.02 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HALO","FFOX","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668976309","title":"Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300","url":"https://stock-news.laohu8.com/highlight/detail?id=2668976309","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668976309?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:10","pubTimestamp":1789679402,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa sells 116 common shares for $20,300Guardant Health director Tariq Musa sold 116 common shares on Sep. 16, 2026 at USD 175.Directly held common stock fell to 11,449 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL5VHhJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","HELX","LU0889565916.HKD","BK4585","PTH","FFOX","LU0109394709.USD","LU0320765992.SGD","BK4588","BK4551","BK4196","GH","BK4535","GNMX","EKG","GDOC","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668995985","title":"US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2668995985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668995985?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:20","pubTimestamp":1789658440,"startTime":"0","endTime":"0","summary":"UPDATE 6-US Health Secretary Kennedy Jr. adds eight new members to key health committeeSept 17 (Reuters)-US Health Secretary Robert F. Kennedy Jr. on Thursday named eight new members to the advisory p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4N4591AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","LU0320765992.SGD","GDOC","FFOX","BK4196","HELX","BK4585","LU0109394709.USD","PTH","LU0889565916.HKD","GNOM","GNMX","BK4588","BK4551","EKG","LFSC","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668998049","title":"Guardant Health on Track for Record High Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2668998049","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668998049?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:16","pubTimestamp":1789654560,"startTime":"0","endTime":"0","summary":"Guardant Health, Inc.  is currently at $180.24, up $5.34 or 3.05%--Would be new all-time closing high --Would be the first new record closing high since Feb. 12, 2021, when it closed at $179.10--On pace for largest percent increase since Sept. 15, 2026, when it rose 4.65%--Currently up three of the past four days--Up 13.34% month-to-date--Up 76.46% year-to-date--Up 206.52% from 52 weeks ago , when it closed at $58.80--Would be a new 52-week closing high--Up 212.53% from its 52-week closing low of $57.67 on Sept. 24, 2025--Traded as high as $181.50; new all-time intraday high --Up 3.77% at today's intraday highAll data as of 10:14:03 AM ETSource: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Guardant Health on Track for Record High Close","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","BK4588","BK4585","GNOM","HELX","LU0320765992.SGD","FFOX","EKG","LU0889565916.HKD","LFSC","BK4535","BK4551","PTH","GH","GNMX","BK4196","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139347293","title":"Japanese Firms Break Ranks to Demand Stronger Yen as Currency Woes Mount","url":"https://stock-news.laohu8.com/highlight/detail?id=1139347293","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139347293?lang=en_us&edition=fundamental","pubTime":"2026-09-17 15:38","pubTimestamp":1789630715,"startTime":"0","endTime":"0","summary":"Corporate leaders across Japan are now pushing for a stronger yen, with even those traditionally benefiting from a weaker currency joining the chorus of concern. Data from the Bank of Japan's July...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXUS","YCS","BAMO","BUFI","HEWJ","KXI","AVDE","TLTI","DUKX","FEOE","AVNM","SHV","ISRVF","NUDM","DFSI","IFEB","JPYmain","AADR","FFOX","FORH","CGIB","VNIE","BLDG","ISRA","BK4585","WBIG","IMAR","IGGY","BK4582","BWZ","PICB","BBIB","ISHP","DIVD","AIRL","TOLL","DIVS","TLT","MOTI","WCMI","PRXI","RWX","SGOV","EBIZ","EQLT","IBCE","DLS","IQLT","PATN","JHID","HFGM","BWX","IJUN","GEOA","EMKT","FEDM","IDVO","PQIN","GMOM","DYNB","GHMS","TINS","JANI","YSEP","ICOW","BBSB","FDRR","SHY","CVIE","WIMA","IAUG","DNL","PPIE","FDTS","BBLB","EUO","ACWI","PIEL","BUFY","RPHS","RSIT","FIVA","TLTX","NTSI","IEF","BBIN","TXXI","EWJ","DSCF","PIEQ","BK4550","IOCT","IFGL","AVSD","DISV","FXY","HEDG","STYL","VIDI","DEEF","TLTW","SEIE","ISCF","IEI","DIM","DUKH","BK4167","IDEC","ISWN","IXUS","TXUE","WIP","TFJL","BKCI","NBIE","ISHG","IDVY","IBUF","IQSI","EMSC","QLVD","JIDE","FLGV","BK4588","TLH","IGOV","GWX","TBJL","EXI","LENS","JPIB","MJYmain","IQDF","YCL","ICPY","TSYW","BGCG","IDV","GXUS","INOV","APLU","GQRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158859379","title":"Brazil's Central Bank Trims Rate to 13.75% as Tight Election Race Clouds Future Easing","url":"https://stock-news.laohu8.com/highlight/detail?id=1158859379","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158859379?lang=en_us&edition=fundamental","pubTime":"2026-09-17 06:00","pubTimestamp":1789596025,"startTime":"0","endTime":"0","summary":"Brazil's central bank cut its benchmark interest rate by 25 basis points on Wednesday, responding to cooling inflation and weakening economic momentum, while a tightly contested presidential race...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUYO","BCFN","DVVY","GMOC","LQID","FITZ","JFLX","PAYH","TAXX","QMY","DFLV","CIK","JAAA","BKLN","SECR","IBHJ","KDRN","SROI","OTGL","VSHY","EVG","IBCE","FNK","SCYB","BK4585","SLWS","BK4588","NUAG","MFSB","THRV","BUCK","CGUI","FNCL","TXXI","PFLD","EVNT","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668936889","title":"Halozyme Therapeutics Slips on $1.05 Bln Convertible Offering Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2668936889","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668936889?lang=en_us&edition=fundamental","pubTime":"2026-09-17 05:10","pubTimestamp":1789593054,"startTime":"0","endTime":"0","summary":"BUZZ-Halozyme Therapeutics slips on $1.05 bln convertible offering plans** Shares of Halozyme TherapeuticsHALO.Odown 1.8% at $106.51 in after hours trading as it seeks capital raise** San Diego, Calif","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL6N458175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","FFOX","HALO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668985935","title":"Halozyme announces proposed offering of $1.05B of 2033 convertible senior notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668985935","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668985935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:35","pubTimestamp":1789590922,"startTime":"0","endTime":"0","summary":"Halozyme (HALO) Therapeutics “announced that it intends to offer, subject to market conditions and other factors, $1.05 billion aggregate principal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/halozyme-announces-proposed-offering-of-1-05b-of-2033-convertible-senior-notes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/halozyme-announces-proposed-offering-of-1-05b-of-2033-convertible-senior-notes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0053671581.USD","FFOX","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668895935","title":"Halozyme Plans USD 1.05 Billion Convertible Senior Notes Offering Due 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2668895935","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668895935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:31","pubTimestamp":1789590696,"startTime":"0","endTime":"0","summary":"Halozyme plans USD 1.05 billion convertible senior notes offering due 2033Halozyme announced a proposed offering of USD 1.05 billion convertible senior notes due 2033.Deal includes a 13-day option for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL8s1KsF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","BK4139","LU0053671581.USD","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668933044","title":"Halozyme Therapeutics, - Expects to Use Net Proceeds to Repurchase Outstanding 2027 and 2028 Convertible Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668933044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668933044?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:30","pubTimestamp":1789590601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA8FSWC6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HALO","FFOX","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668330229","title":"Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes Due 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2668330229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668330229?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:30","pubTimestamp":1789590601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA8FSWC6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0053671581.USD","HALO","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667898849","title":"FireFox Gold Uncovers New High-Grade Lammas Zone at Mustajärvi Project in Finland","url":"https://stock-news.laohu8.com/highlight/detail?id=2667898849","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667898849?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:56","pubTimestamp":1789559762,"startTime":"0","endTime":"0","summary":"An update from FireFox Gold ( ($TSE:FFOX) ) is now available. FireFox Gold has announced the discovery of the Lammas Zone, a newly recognized high-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/firefox-gold-uncovers-new-high-grade-lammas-zone-at-mustajarvi-project-in-finland?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/firefox-gold-uncovers-new-high-grade-lammas-zone-at-mustajarvi-project-in-finland?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGCmain","159934","SGUmain","GDX","IAU","NUGT","DUST","518880","GLD","GCmain","SGCmain","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667062145","title":"Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667062145","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667062145?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:02","pubTimestamp":1789498945,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) stands to benefit from AstraZeneca's (AZN) failed Serena-4 trial because the result preserves the biomarker-driven monitoring approach supporting potential demand for its Guardant","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZN","HELX","LU2089984988.USD","LU1267930573.SGD","GH","LU0432979614.USD","LU0889565916.HKD","LU0128525929.USD","LU2468319806.SGD","BK4585","LU2237443382.USD","BK4588","LU2237443549.SGD","AZNH","LU0289739699.SGD","LU0058720904.USD","LU2236285917.USD","LU0109394709.USD","PTH","EKG","BK4535","BK4007","FFOX","LU0310800379.SGD","IE00B3T34201.USD","GNOM","LU2456880835.USD","BK4551","LU0320765992.SGD","LU2417539215.USD","BK4568","LU2237443978.SGD","LU2237443465.HKD","LU0029864427.USD","GDOC","LU2237443622.USD","LU2462157665.USD","LU1829250122.USD","BK4196","GNMX","LU0708994859.HKD","LFSC","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667569983","title":"Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2667569983","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667569983?lang=en_us&edition=fundamental","pubTime":"2026-09-15 06:12","pubTimestamp":1789423938,"startTime":"0","endTime":"0","summary":"Guardant Health CIO Kumud Kalia disposes of 4,000 common shares worth $632,193.20Guardant Health Chief Information Officer Kumud Kalia sold 4,000 common shares on Sept. 11, 2026.The sale price was USD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL3DVtS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GH","BK4585","LFSC","LU0109394709.USD","FFOX","HELX","GNMX","PTH","GDOC","GNOM","LU0889565916.HKD","LU0320765992.SGD","BK4196","BK4551","EKG","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667087693","title":"Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2667087693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667087693?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:07","pubTimestamp":1789416443,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560HZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","GDOC","FFOX","GH","GNMX","EKG","GNOM","BK4551","LU0889565916.HKD","HELX","LU0109394709.USD","BK4585","PTH","BK4196","LFSC","LU0320765992.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666570911","title":"Halozyme CEO Helen Torley Reports Disposal of Common Shares Worth USD 6.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666570911","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666570911?lang=en_us&edition=fundamental","pubTime":"2026-09-12 08:35","pubTimestamp":1789173359,"startTime":"0","endTime":"0","summary":"Halozyme CEO Helen Torley reports disposal of common shares worth USD 6.5 millionHalozyme CEO Helen Torley reported option exercises totaling 60,000 shares from Sept. 9-11, 2026 at USD 18.41.Disposed ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260912:nNDL9QbYMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Halozyme CEO Helen Torley Reports Disposal of Common Shares Worth USD 6.5 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HALO","FFOX","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666368655","title":"UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666368655","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666368655?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:35","pubTimestamp":1788960920,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $198.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GNOM","EKG","BK4196","GNMX","LU0109394709.USD","LFSC","BK4535","BK4588","GDOC","BK4551","BK4585","LU0320765992.SGD","FFOX","GH","HELX","PTH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373511","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373511?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:51","pubTimestamp":1788871865,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Guardant Health (GH) and Neurocrine (N...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU0289739699.SGD","XBI","IBBQ","IE00BJT1NW94.SGD","LU2468319806.SGD","LFSC","PBE","PTH","BK4588","BK4535","LU0154245673.USD","TBXU","FFOX","HELX","AMGN","IE00B2B36J28.USD","LU0029874061.USD","LU0109394709.USD","GDOC","LU2065170008.USD","LU1571399168.USD","LU1061106388.HKD","IE0002141913.USD","GNOM","BK4137","LU1057294990.SGD","BK4585","IE00BFTCPJ56.SGD","IBB","GH","LU0823416689.USD","BK4533","BIB","BK4599","IE0009355771.USD","NBIX","LU2242646821.SGD","LABU","BBH","HCSG","LU0154245756.USD","LU0889565916.HKD","BK4534","LU2242652126.USD","GNMX","PJP","EKG","BK4139","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378332","title":"Guardant Health Price Target Announced at $203.00/Share by Rothschild & Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378332","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378332?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:26","pubTimestamp":1788870360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","EKG","PTH","BK4588","FFOX","BK4585","GNMX","GNOM","HELX","LU0109394709.USD","BK4535","LFSC","LU0320765992.SGD","LU0889565916.HKD","BK4551","BK4196","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321994","title":"Guardant Health's Breast Cancer Diagnostic Approved by US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321994","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665321994?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:08","pubTimestamp":1788862114,"startTime":"0","endTime":"0","summary":"Guardant Health's  Guardant360 CDx has been approved by the US Food and Drug Administration as a companion diagnostic for advanced metastatic breast cancer, the company said Friday.The specific indication for the diagnostic combination is to identify patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer harboring tumors with specific mutations before radiographic progression who may benefit from treatment with AstraZeneca's  Etcamah, the company said.The approval is based on data from a clinical trial showing a 56% reduction in the risk of progression or death, the company said.Shares of the company were up 1% in recent premarket trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GDOC","LU0289739699.SGD","LU2417539215.USD","GNOM","LU0889565916.HKD","LU2089984988.USD","BK4007","PTH","LU2237443895.HKD","FFOX","BK4551","LU0708994859.HKD","LU2237443622.USD","LFSC","BK4535","EKG","LU2237443382.USD","HELX","BK4568","LU2468319806.SGD","LU2237443549.SGD","LU2462157665.USD","LU0310800379.SGD","LU2236285917.USD","LU0109394709.USD","LU1829250122.USD","LU2237443465.HKD","BK4585","LABU","LU0128525929.USD","BK4196","GNMX","AZNH","LU0320765992.SGD","LU0432979614.USD","LU1267930573.SGD","IE00B3T34201.USD","LU2237443978.SGD","GH","BK4588","LU0029864427.USD","AZN","LU0058720904.USD","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":96,"code":"91000000","status":"200"}]}}